Natural Product: NPC469644

Natural Product IDNPC469644
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Trogopteroid F
IUPAC Name (4bS,8S,8aR,9R)-8-(hydroxymethyl)-4b,8-dimethyl-3-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-2,9-diol
Synonyms Trogopteroid F
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1095965
PubChem CID 46887196
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WGRNQBCIHDDIMK-IYWMVGAKSA-N
Standard InCHI InChI=1S/C20H30O3/c1-12(2)14-10-15-13(8-16(14)22)9-17(23)18-19(3,11-21)6-5-7-20(15,18)4/h8,10,12,17-18,21-23H,5-7,9,11H2,1-4H3/t17-,18+,19-,20-/m1/s1
SMILES CC(C)C1=C(C=C2CC(C3C(CCCC3(C2=C1)C)(C)CO)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   318.22 Volume:   347.268
?
Van der Waals volume.
Dense:   0.916 LogP:   2.799
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.769
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.625
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   16.0
TPSA:   60.69
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   3.0 Rings:   3.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.782 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.142 Fsp3:   0.7
MCE-18:   76.353
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.079 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.095
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.046
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.14 Promiscuous compounds:   0.037

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.752 MDCK Permeability:   -4.832
Pgp-inhibitor:   0.007 Pgp-substrate:   0.283
PAMPA:   0.289
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.04
20% Bioavailability (F20%):   0.688 30% Bioavailability (F30%):   0.934
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.192 MRP1:   0.987
Plasma Protein Binding (PPB):   83.684% Volume Distribution (VD):   0.481
Fu: 22.408%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.419
OATP1B3 inhibitor:   0.854 BCRP inhibitor:   0.103
BSEP inhibitor:   0.723

ADMET: Metabolism

CYP1A2-inhibitor:   0.2 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.101 CYP2C19-substrate:   0.003
CYP2C9-inhibitor:   0.988 CYP2C9-substrate:   0.002
CYP2D6-inhibitor:   0.796 CYP2D6-substrate:   0.526
CYP3A4-inhibitor:   0.962 CYP3A4-substrate:   0.075
CYP2B6-substrate:   0.003 CYP2C8-inhibitor:   0.211
HLM stability:   0.265
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.557 Half-life (T1/2):  1.662

ADMET: Toxicity

hERG Blockers:  0.082 hERG Blockers (10um):  0.572
Human Hepatotoxicity (H-HT):  0.566 Drug-induced Liver Injury (DILI):  0.111
AMES Toxicity:  0.302 Rat Oral Acute Toxicity:  0.298
Maximum Recommended Daily Dose:  0.759 Skin Sensitization:  0.192
Carcinogencity:  0.593 Eye Corrosion:  0.0
Eye Irritation:  0.357 Respiratory Toxicity:  0.657
Drug-induced Neurotoxicity:  0.162 Ototoxicity:  0.927
Hematotoxicity:  0.211 Drug-induced Nephrotoxicity:  0.43
Genotoxicity:  0.021 RPMI-8226 Immunitoxicity:  0.046
A549 Cytotoxicity:  0.123 Hek293 Cytotoxicity:  0.522
BCF:   1.818
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.126
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.583
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.901
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota feces n.a. n.a. PMID[20402524]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO882 Trogopterus xanthipes Species Sciuridae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell line HepG2 Homo sapiens IC50 > 40000.0 nM PMID[21846091]
NPT116 Cell line HL-60 Homo sapiens IC50 > 40000.0 nM PMID[3755758]
NPT15 Cell line Jurkat Homo sapiens IC50 > 40000.0 nM DrugMatrix in vivo data: Hematology
NPT466 Cell line U-937 Homo sapiens IC50 > 40000.0 nM PMID[17570664]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC469644 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6852 Remote Similarity NPC606176
0.6852 Remote Similarity NPC606869
0.6667 Remote Similarity NPC38893
0.6667 Remote Similarity NPC469663
0.6607 Remote Similarity NPC479465
0.5965 Remote Similarity NPC192948
0.5965 Remote Similarity NPC35797
0.5714 Remote Similarity NPC176279
0.541 Remote Similarity NPC605657
0.5246 Remote Similarity NPC179467
0.5172 Remote Similarity NPC92
0.5167 Remote Similarity NPC604782
0.5085 Remote Similarity NPC220596

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469644 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data